CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease Metro Vaartha dated 20th December 2022

CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease Metro Vaartha dated 20th December 2022. Metro Vaartha.

[img]
Preview
Text
Metro Vaartha_20-12-2022.pdf

Download (79kB) | Preview
Official URL: https://www.english.metrovaartha.com/news/80347/cm...
Related URLs:

    Abstract

    The Central Marine Fisheries Research Institute (CMFRI) has signed an MoU for the production of Cadalmin LivCure extract, a patent-protected nutraceutical product from seaweeds, to combat non-alcoholic fatty liver disease (NAFLD). A Memorandum of Understanding (MoU) was inked with Emineotech, a private limited company dealing with health products, for commercial production and marketing of the product.

    Item Type: Article
    Subjects: CMFRI News Clippings
    Divisions: CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division
    Subject Area > CMFRI > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division
    CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division
    Subject Area > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division
    Depositing User: Mr. Augustine Sipson N A
    Date Deposited: 28 Dec 2022 07:08
    Last Modified: 28 Dec 2022 07:08
    URI: http://eprints.cmfri.org.in/id/eprint/16560

    Actions (login required)

    View Item View Item